Accepted: 3 April 2017

DOI: 10.1111/irv.12455


ORIGINAL ARTICLE



School-­based surveillance for influenza vaccine effectiveness
during 2014-­2015 seasons in Hong Kong

Ting F. Leung1                 | Renee W. Y. Chan1 | Angela Kwok2 | Wendy C. S. Ho2 |
Mars K. P. Tao1 | Kam L. Hon1 | Frankie W. T. Cheng1 | Albert M. Li1 | Paul K. S. Chan2

1
 Department of Paediatrics, Prince of Wales
Hospital, The Chinese University of Hong            Background: Influenza imposes substantial healthcare burden in children, which can
Kong, Shatin, Hong Kong                             be prevented by vaccination. Influenza vaccination coverage varies widely among
2
 Department of Microbiology, Prince of Wales        childhood populations worldwide, which has significant impact on herd immunity and
Hospital, The Chinese University of Hong
Kong, Shatin, Hong Kong                             usefulness of influenza vaccine. However, there are limited real-­life data on influenza
                                                    vaccine effectiveness (VE) in children.
Correspondence
Ting F. Leung, Department of Paediatrics, Lui       Objective: This prospective study aimed to investigate clinical spectrum of childhood
Che Woo Clinical Sciences Building, Prince of       influenza and VE in preventing influenza in Hong Kong children.
Wales Hospital, Shatin, Hong Kong.
Email: tfleung@cuhk.edu.hk                          Methods: A total of 623 children were recruited from 15 kindergartens and primary

Funding information                                 schools. Parents completed a questionnaire on subjects’ health and influenza vaccina-
This study was supported by Health and              tion history. Flocked nasopharyngeal swabs (FNPSs) were collected in biweekly school
Medical Research Fund Reference No.
13120422 of Hong Kong SAR Government.               visits during 2014-­2015 influenza seasons. Influenza A and B viruses were detected
The funding source had not been involved            and typed by molecular assays.
in study design; collection, analysis, and
interpretation of data; writing of this             Results: A total of 2633 FNPS samples were collected, with two or more samples
manuscript; and the decision to submit this         being obtained from 607 (97.4%) of subjects. Thirty-­six (11.2%) subjects had influenza
article for publication
                                                    A or B in 2014, whereas all 19 (6.3%) subjects identified in 2015 had influenza A.
                                                    Ninety-­nine subjects reported influenza-­like illness (ILI), and nine illness visits were
                                                    arranged. Influenza vaccination was protective against ILI but not mild laboratory-­
                                                    confirmed influenza by surveillance. Moderate overall influenza VE of 42%-­52% was
                                                    observed for ILI, and subgroup analyses showed much higher VE for both ILI (70.9% vs
                                                    34.6%) and mild laboratory-­confirmed influenza (44.0% vs −6.2%) in school-­age chil-
                                                    dren than preschoolers who were vaccinated within 12 months.
                                                    Conclusions: Mild laboratory-­confirmed influenza infection is common in children dur-
                                                    ing influenza seasons. Influenza vaccination is effective against ILI but not mild infec-
                                                    tion identified by surveillance.

                                                    KEYWORDS
                                                    epidemiology, influenza, surveillance, vaccine effectiveness




1 | INTRODUCTION                                                                    influenza-­like illness (ILI) by 36% in healthy children.3 However, there
                                                                                    are limited post-­licensure effectiveness data in Asian children. In the
Influenza is an important healthcare burden in Hong Kong1,2, and influ-             European sentinel surveillance networks, seasonal influenza vaccine
enza vaccination reduced laboratory-­confirmed influenza by 59% and                 had low-­to-­moderate effectiveness of 43% against influenza A (H3)

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2017 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Influenza Other Respi Viruses. 2017;11:319–327.                                  ﻿ 
                                                                                   wileyonlinelibrary.com/journal/irv                                         |   319
      |




                                                                                                                                                          17502659, 2017, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/irv.12455, Wiley Online Library on [17/11/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
320                                                                                                                                       LEUNG et al.


in the early 2011/2012 season.4 Similar level of vaccine effectiveness        representative study population. Based on local data3, we targeted
(VE) was reported from 19 influenza surveillance sites in Guangzhou5,         this surveillance in consecutive influenza seasons in 2014-­2015. The
supporting the need to delineate the effectiveness of seasonal influ-         Joint Chinese University of Hong Kong-­New Territories East Cluster
enza vaccine in children. The reported figure of laboratory-­confirmed        Clinical Research Ethics Committee approved this study.
cases underestimates true case numbers as surveillance only fo-
cused on severe cases. More than one-­third of household contacts
                                                                              2.2 | Subject assessment
of A(H1N1)pdm09-­infected patients who had serologic evidence of
pandemic influenza were asymptomatic.6 Children with mild influenza           Parents completed a questionnaire that recorded subjects’ demo-
infection impose a public health concern by perpetuating influenza            graphics, pre-­
                                                                                            existing medical illnesses, and influenza vaccination
transmission in the community. Nonetheless, there is a lack of stud-          history within 3 years. Our staff verified vaccination history against
ies that reported influenza VE in preventing asymptomatic or mildly           immunization cards or with responsible doctors. Subjects with the
symptomatic influenza. Our smaller local study with biweekly naso-            following criteria were considered vaccinated: (i) ≥14 days post-­
pharyngeal sampling revealed that influenza B virus was detected in           vaccination; (ii) received two doses 28 days apart if vaccinated for the
                                                      7
18% and 30% of asymptomatic and sick children. Influenza surveil-             first time; or (iii) received at least one dose in a previous influenza
lance in prospective cohorts is thus necessary to define the full spec-       season and one dose in the season under study.5 For surveillance
trum of influenza. Because of viral antigenic drift, annual estimates         samples, serial flocked nasopharyngeal swabs (FNPSs) were collected
of influenza VE would provide important data to monitor any change            every 2 weeks during school visits regardless of whether subjects had
                                                              8
in the impact of seasonal influenza vaccination program. This point           respiratory symptoms. Surveillance samples were collected between
was illustrated by the surge of influenza in 2014/2015 season due             February and June in 2014 and between January and February in
to mismatch between vaccine A/H3N2 strain and the new circulating             2015. We started school surveillance within 2 weeks upon announce-
A/H3N2_Switzerland strain (http://www.chp.gov.hk/en/view_con-                 ment of the start of influenza seasons by our CHP. This active influ-
tent/18632.html).9 The Centre for Health Protection (CHP) of Hong             enza surveillance could detect children with asymptomatic or mildly
Kong recommended influenza vaccine containing A/California/7/2009             symptomatic infections, which provided an unbiased data on the full
A(H1N1)pdm09-­like virus, A/Switzerland/9715293/2013 (H3N2)-­like             spectrum of influenza infections.
virus, and B/Phuket/3073/2013-­like virus for the 2015/16 season.                Our staff phoned families every 2 weeks to remind subjects about
This school-­based surveillance study identified the spectrum of both         the next surveillance visits and enquire whether they had ILI defined
subclinical and clinical influenza in children and risk factors for such      based on modified World Health Organization (WHO) case definition
infections in Hong Kong preschool and school-­age children. We also           (ie, fever ≥38°C plus two of the followings: cough, sore throat, rhinor-
aimed to report influenza VE against influenza and ILI in these two           rhea, myalgia, headache)10 and whether they recently received influ-
pediatric age groups.                                                         enza vaccination. Parents were provided our contact phone number
                                                                              and encouraged to inform us as soon as their children developed ILI.
                                                                              Our team attempted to arrange illness visit for all subjects with ILI
2 | MATERIALS AND METHODS
                                                                              during influenza seasons in early 2014 and 2015, and those agreed
                                                                              to attend illness visit returned to our outpatient clinic within 48 hours
2.1 | Study population
                                                                              of ILI onset. During these visits, our nurse collected illness sample and
This prospective cohort study recruited children in two grades of             recorded clinical features and concurrent medications.
kindergartens (K.1 [~3 years old] and K.3 [~5 years old]) and primary
schools (P.2 [~7 years old] and P.5 [~10 years old]) in the Kowloon
                                                                              2.3 | NPS collection and processing
and New Territories Easter regions of Hong Kong that have a resid-
ing population of 300 000 children aged below 15 years according to           Nasopharyngeal sample was collected using flocked swab (Copan
census data in 2011. For our sampling strategy, our team generated            Diagnostics, Corona, CA).11,12 Swabs taken from both nostrils of
the first randomly selected batch of 20 kindergartens and 20 primary          a subject were placed in the same specimen bottle containing viral
schools from all those registered with the Education Bureau of Hong           transport medium and transported within 4 hours at room tempera-
Kong Government, contacted the school principals for participation in         ture to virology laboratory, where swabs were discarded after vortex-
this surveillance study, and then generated additional random batches         ing for 20 seconds to release the cells. Viral transport medium was
until our target sample size of 560 children was achieved. We recruited       then centrifuged and the pellet resuspended in 1 mL buffered saline
about half of target sample size from all eligible classes of kindergar-      and stored at −80°C until analyses.
tens and another half from all eligible classes of primary schools. At
the study start, we contacted principals of selected kindergartens and
                                                                              2.4 | Real-­time PCR for influenza virus detection
primary schools to obtain their permission to join this study. Parents
of eligible students in these schools then gave informed written con-         Viral RNA was extracted with PureLink® Viral RNA/DNA Mini Kit
sent for their children to participate in this surveillance. This study did   (Life Technologies, Waltham, MA, USA) according to manufacturer’s
not set any exclusion criterion for subjects in an attempt to recruit a       instructions. RNA was eluted with 50 μL sterile RNAse-­free water
                                                                                                                                              | 321




                                                                                                                                                      17502659, 2017, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/irv.12455, Wiley Online Library on [17/11/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
LEUNG et al.


and stored at −80°C before use. Influenza A and B M gene-­specific          including seasonality (month of study), subjects’ age, sex, body mass
                                                                    ®
real-­time (RT)-­PCR was performed in parallel using SuperScript III        index, and comorbid medical conditions. Surveillance data from all in-
Platinum® One-­
              Step Quantitative RT-­
                                   PCR System with ROX (Life                fluenza seasons were combined during such analyses. Influenza VE
Technologies). The RT-­qPCR reaction contained 5 μL of purified RNA,        was estimated by the “test-­negative case-­control” design according to
0.5 μL of SuperScript® III/Platinum® Taq Mix (Life Technologies),           published method.14 As vaccine recipients may have a greater likeli-
12.5 μL of 2× reaction mix in a final reaction volume of 25 μL. The         hood of seeking health care should they develop infections, this ana-
sequences of primers for influenza A were as follows: (FLUAM-­7F)           lytical approach adjusts implicitly for this confounding which would
CTT CTA ACC GAG GTC GAA ACG TA; (FLUAM-­161R) GGT GAC                       otherwise bias VE. All analyses were performed two-­tailed using SPSS
AGG ATT GGT CTT GTC TTT A; and (FLUAM-­49-­P4) YAK-­TCA GGC                 v.21 (Chicago, IL, USA), with 0.05 being the level of significance.
CCC CTC AAA GCC GAG-­BHQ1. The primers for influenza B included
the following: (FLUBHA-­108F) AGG GGA GGT CAA TGT GAC TG;
                                                                            3 | RESULTS
(FLUBHA-­209R) GGG CAT AGT TTC CCT CTG GT; and (FLUBHA-­
165P) FAM-­TTT TGC AAA TCT CAA AGG A-­MGB. The concentra-
                                                                            3.1 | Study population
tions were 0.3 μMol L−1 for influenza A primers and 0.24 μMol L−1
and 0.2 μMol L−1 for influenza B primers. The cycling conditions were       Five of 97 invited primary schools and 10 of 238 invited kindergartens
50°C for 30 minutes, 95°C for 2 minutes, followed by 40 cycles of           agreed to participate. A total of 630 children aged 7.3±2.4 years were
95°C for 15 seconds and 60°C or 56°C for 30 seconds, for influenza          recruited, including 322 children in 2014 and 308 children in 2015.
A or influenza B respectively. RNA standards were prepared using the        All subjects participated either in 2014 or 2015 seasons but not both.
MEGAscript® T7 Transcription Kit (Life Technologies), aliquoted, and        Seven subjects (one in 2014 and six in 2015) withdrew consent before
stored at −80°C. To generate the standard curve, 10-­fold serial dilu-      FNPS collection. A total of 333 (53.5%) subjects received influenza
tions of the RNA transcripts were performed to cover the concentra-         vaccination within 3 years, with 78, 75, and 180 children being vac-
                  6   1
tion range of 10 -­10 copies/μL of standard. Amplification, detection,      cinated in one, two, and 3 years, respectively.
and data analysis were performed with StepOnePlus™ Real-­Time PCR              Table 1 summarizes the characteristics of children who provided
System (Life Technologies).                                                 ≥one surveillance sample. Most children recruited in 2014 provided
                                                                            six to seven samples and those recruited in 2015 gave two to three
                                                                            samples (Figure 1A). A total of 2633 FNPS samples were collected
2.5 | Typing of influenza A and B viruses
                                                                            from 623 children. Two FNPSs were obtained from 607 (97.4%) sub-
The molecular diagnosis of influenza virus from 28 influenza A posi-        jects and three samples from 505 (81.1%) subjects. ILI episodes were
tive and 31 influenza B positive samples were based on the WHO              reported by 99 subjects, consisting of 63 (26.7%) of 236 preschoolers
guidelines     (http://www.who.int/csr/disease/influenza/manual_diag-       and 36 (9.3%) of 387 school-­age children (P<.001). FNPS was not ob-
nosis_surveillance_influenza/en/index.html) with slight in-­house modi-     tained from these subjects because of unavailability of research staff
fications. Extracted RNA (50 ng) was subjected to reverse transcription     to conduct home visit. In addition, nine illness visits were arranged
using Superscript II (Life Technologies). For the subtyping of the in-      for five subjects. There was no ILI outbreak in schools or reported
fluenza, primers were based on WHO guidelines which targeted the            transmission of influenza within the same classes and household of
hemagglutinin gene-­
                   specific for A(H1N1)pdm09, A/H3, B/Victoria-­            influenza-­infected children.
lineage, and B/Yamagata-­lineage. Conventional PCR were performed
using AmpliTaq Gold 360 Master Mix (Life Technologies), and the PCR
                                                                            3.2 | Detection of influenza virus in
products were resolved in 2% agarose gel. Samples showing expected
                                                                            surveillance samples
band size after 50 amplification cycles were considered positive.
   Viral load was expressed in the absolute copy numbers of influenza       Influenza A and B viruses were detected in surveillance samples from
M gene determined from the standard curves generated from a stan-           27 to 30 subjects respectively, with median (IQR) viral loads of 918
dard plasmid with a known copy number in serial dilutions, which was in-    (99-­14 864) copies/μL and 262 (98-­324 027) copies/μL, and which
cluded in the quantitative PCR simultaneously, as previously described.13   were similar between preschool and school-­
                                                                                                                      age children (P>.15).
Real-­time PCR was conducted using SYBR Premix EX Taq master mix            Figure 1B illustrates influenza detection in 2014 and 2015. Influenza
(Takara Kusatsu, Shiga, Japan), and the results were analyzed using         B predominated in 2014 and influenza A in 2015 (P<.001). One sub-
PRISM 7900HT system (Applied Biosystems, Foster City, CA, USA).             ject had influenza A and B co-­infection in February 2014, and another
                                                                            subject had influenza A in February 2014 followed by influenza B
                                                                            4 weeks later. Overall, 36 (11.2%) of 321 subjects had influenza A or B
2.6 | Statistical analysis
                                                                            infection in 2014 whereas all 19 (6.3%) of 302 subjects had influenza
Numerical data were expressed either in mean and standard devia-            A infection in 2015.
tion (SD) or median and interquartile range (IQR) as appropriate. The          Six influenza A and 11 influenza B were not typable due to low
occurrence of laboratory-­confirmed influenza or ILI in relation to vac-    virus load. For the remaining isolates, seven influenza A were A(H1N1)
cination was analyzed by logistic regression, adjusting for covariates      pdm09 and 14 were H3-­positive whereas among influenza B isolates,
       |




                                                                                                                                                                                  17502659, 2017, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/irv.12455, Wiley Online Library on [17/11/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
322                                                                                                                                                                LEUNG et al.


T A B L E 1 Demographic and clinical features of study participants                (A)250
in 2014 and 2015

                                        Result                                                       200

                                        2014




                                                                             Number of subjects
 Parameter                              (n=321)           2015 (n=302)                               150
                                                      a
 Age in years, mean±SD                     7.0±2.7              7.7±2.1
 Male                                   173 (53.9)        162 (53.6)                                 100
                                                                                                                                 221

 Born in Hong Kong                      257 (80.1)        260 (86.1)
 Paternal secondary or university       243 (75.7)        232 (76.8)                                                                                   116   114
                                                                                                           50            102
  education
 Maternal secondary or university       248 (77.3)        240 (79.5)                                                                    23     28
                                                                                                                16                                                    3
  education                                                                                                 0
                                                                                                                1            2    3     4       5       6     7       8
 History of influenza vaccination
                                                                                                                     Number of NPS samples collected
      Within 3 y                        162 (50.5)        171 (56.6)
      At 25-­36 mo ago                  115 (35.8)        125 (41.4)               (B) 30
                                                                                                                                                                          2014
      At 13-­24 mo ago                  127 (39.6)        129 (42.7)                                                                                                      2015
                                                                                                           25
      Within 12 mo                      134 (41.7)        132 (43.7)




                                                                                      Number of subjects
 History of pneumococcal                148 (46.1)        123 (40.7)                                       20
  vaccination
 Asthma phenotypes                                                                                         15

      Wheeze ever                        59 (18.4)         49 (16.2)
                                                                                                           10
      Current wheeze                     40 (12.5)          26 (8.6)
      Asthma ever                         21 (6.5)          18 (6.0)                                        5
 Rhinitis ever                          103 (32.1)        119 (39.4)
                                                                                                            0
 Eczema ever                             81 (25.2)         84 (27.8)                                                 Flu A             Flu A & Flu B          Flu B
 Environmental exposures
                                                                            F I G U R E 1 (A) Distribution of FNPS sample collection from our
      Breastfeeding ever                187 (58.3)        160 (53.0)
                                                                            subjects, with two or more FNPS being collected from 320 (99.4%)
      Breastfeeding for 4 mo and        106 (33.0)         87 (28.8)
                                                                            subjects in 2014 and 295 (95.8%) subjects in 2015; and (B) detection
       longer
                                                                            of influenza A and B viruses by surveillance in years 2014 and 2015
      Current cat/dog keeping             25 (7.8)          28 (9.3)
      Current bird keeping                  3 (0.9)          1 (0.3)
      Current maternal smoking            28 (8.7)          29 (9.6)
                                                                            3.3 | Relationship between ILI and subjects’
      Maternal smoking during infancy     11 (3.4)           5 (1.7)
                                                                            demographic and clinical factors
                                                      b
      Maternal smoking during               9 (2.8)          1 (0.3)        Table 2 summarizes the relationship between occurrence of ILI and
       pregnancy                                                            subjects’ personal, clinical, and vaccine factors. Subjects with ILI were
      Current domestic smoking          137 (42.7)        114 (37.7)        younger than those without ILI (P<.001), but ILI was not associated with
       exposure
                                                                            any environmental or clinical factor. Influenza vaccination at all time
      Indoor dampness or visible        122 (38.0)        101 (33.4)        points was protective against ILI (P=.002-­.022). Logistic regression con-
       molds
                                                                            firmed such association for influenza vaccination within 3 years (odds
Results expressed in number (percentage) unless stated otherwise.           ratio 0.49, 95% confidence interval 0.29-­0.81; P=.005). None of the
a
 P<.001.
b                                                                           other factors enlisted in Table 2 was associated with mild laboratory-­
  P<.05.
                                                                            confirmed influenza detected by surveillance (data not shown).


all detected in 2014, nine were in Yamagata-­lineage and 10 belonged to
                                                                            3.4 | Effectiveness of influenza vaccination
Victoria-­lineage. Influenza A (total seven) was typed into four A(H1N1)
pdm09 and one A/H3 in 2014 and three A(H1N1)pdm09 and 13 A/H3               Sixty-­three (18.9%) subjects who received influenza vaccination within
in 2015 (P=.025). None of these children were reported by parents to be     3 years had either IL-­
                                                                                                  I or laboratory-­
                                                                                                                  confirmed influenza detected
“sick” at the time of FNPS collection. Besides, our nurses did not notice   by surveillance, which was significantly lower when compared to 86
significant respiratory symptoms in these children at the time of FNPS      (29.7%) children who were not vaccinated (P<.005). Table 3 illustrates
collection. All illness FNPS samples were negative for both influenza A     the results for influenza VE in our children. Influenza vaccination was
and B.                                                                      protective against ILI (P<.005) but not mild laboratory-­
                                                                                                                                    confirmed
                                                                                                                                                 | 323




                                                                                                                                                           17502659, 2017, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/irv.12455, Wiley Online Library on [17/11/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
LEUNG et al.


T A B L E 2 Relationship between occurrence of ILI and                          36%-­44% among Hong Kong children, and overall influenza VE was
demographic, environmental, and allergy factors                                 moderate (42%-­
                                                                                              52%) for ILI. Influenza vaccination was effective

 Factor                         ILI (n=99)       No ILI (n=524)    P   a        against ILI but not mild infection identified by our surveillance. More
                                                                                importantly, influenza VE was substantially higher for both ILI and mild
 Male                           55 (55.6)        272 (51.9)         .505
                                                                                laboratory-­confirmed influenza in school-­age than preschool children.
 Age in years, mean±SD                5.8±2.2           7.6±2.4    <.001
                                                                                   The prospective cohort design of this study offers an ideal ap-
 Born in Hong Kong              87 (87.9)        423 (80.7)         .090
                                                                                proach for respiratory virus surveillance. A significant proportion of
 Environmental exposures                                                        patients with respiratory viral infections only suffer from mild symp-
   Breastfeeding ever           60 (60.6)        282 (53.8)         .213        toms.15-17 Patients with influenza may only have mild cough and rhi-
   Current domestic             39 (39.4)        210 (40.1)         .899        norrhea. Our investigative approach detected 104 children with ILI
    smoking exposure                                                            and 55 children with mild laboratory-­confirmed influenza during in-
   Current maternal smoking         8 (8.1)         48 (9.2)        .731        fluenza seasons in 2014-­2015. We acknowledge that some ILI cases
   Current dog/cat keeping      10 (10.1)           43 (8.2)        .535        were not due to influenza because most of these children had not
   Indoor dampness or           41 (41.1)        180 (34.4)         .178        been tested for influenza. Nonetheless, we believe that these num-
    visible molds                                                               bers would be a better reflection of the clinical spectrum for influenza
   Presence of elder            24 (24.2)        117 (22.3)         .676        infections in children.
    brother                                                                        Randomized controlled trials demonstrated efficacy of influenza
   Presence of elder sister     25 (25.3)        103 (19.7)         .206        vaccination4,5,18-20, but such findings being obtained in an optimal
 Allergy phenotypes                                                             setting may not be generalizable to the real-­life situation. A sys-
   Wheeze ever                  18 (18.2)         89 (17.0)         .772        tematic review showed low influenza VE (often less than 60%) for
   Current wheeze               12 (12.1)         53 (10.1)         .549        subjects risk of severe infection.21 The Influenza Monitoring Vaccine

   Asthma ever                      5 (5.1)         34 (6.5)        .588        Effectiveness in Europe project found 43% VE in 2011/12.4 Multiple
                                                                                confounding factors such as difficulty in matching influenza A an-
   Use of asthma medica-            4 (4.0)         13 (2.5)        .329
    tion in past 12 mo                                                          tigen for the vaccine strain vs the dominant circulating viruses22,
   Rhinitis ever                31 (31.3)        188 (35.9)         .383        suboptimal vaccine uptake, and poor infection control practices in-

   Eczema ever                  26 (26.3)        137 (26.1)         .981        fluenced influenza VE. This prospective surveillance study was de-
                                                                                signed in this direction with biweekly surveillance for influenza A
 History of influenza vaccination
                                                                                and B viruses by molecular methods. Thus, our results supported
   Within 3 y                   39 (39.4)        294 (56.1)         .002
                                                                                seasonal influenza vaccine to be an effective public health measure
   At 25-­36 mo ago             28 (28.3)        212 (40.5)         .022
                                                                                to prevent ILI in local children. Subgroup analyses revealed that in-
   At 13-­24 mo ago             27 (27.3)        229 (43.7)         .002
                                                                                fluenza vaccination might be more effective against both ILI and mild
   Within 12 mo                 29 (29.3)        237 (45.2)         .003
                                                                                laboratory-­confirmed influenza in school-­age than preschool children
 Ever received pneumococ-       50 (50.5)        220 (42.0)         .117        (Table 4). Another local study reported age-­specific VE for influenza-­
  cal vaccine
                                                                                related hospitalization to be higher in children aged 3-­5 years than
ILI, influenza-­like illness; SD, standard deviation.                           6-­17 years (91.4% vs 58.1%) in 2015-­16.23 However, both this and
Results expressed in number (percentage) unless stated otherwise.
a                                                                               our studies were limited by small sample size in each age group which
 Analyzed by Student’s t test for age and χ2 or Fisher’s exact test for other
variables as appropriate.                                                       led to wide 95% confidence intervals and significant overlap of the
                                                                                VE estimates. Similar findings were observed in a study of 2368 inpa-
influenza when subjects were vaccinated within 3 years or 12 months.            tients in Beijing in the 2014-­2015 season24, a Japanese surveillance
Influenza vaccine was moderately protective against ILI with VE varied          in 2013-­201425, and two US studies in 2013-­2014 and 2014-­2015
between 42.1% and 51.9% when subjects were vaccinated at different              seasons26,27. Our finding supported possible impact of extending the
time points before this study. On the other hand, influenza vaccination         influenza vaccination programs to school-­age children, but further
could not prevent mild laboratory-­confirmed influenza that was identi-         studies are needed to address the cost-­effectiveness of this vacci-
fied by surveillance. Table 4 provides VE results in different age sub-         nation strategy.
groups. Influenza VE was substantially higher among school-­age than               Our findings of four A(H1N1)pdm09 and one A/H3 in 2014 and
preschool children, with 70.9% vs 34.6% for ILI and 44.0% vs −6.2%              three A(H1N1)pdm09 and 13 A/H3 in 2015 among the typable vi-
for mild influenza infection among those vaccinated within 12 months.           ruses were consistent with local surveillance data of A(H1N1)pdm09
                                                                                dominance from early January 2014 to early March 2014 and A/H3N2
                                                                                dominance from late December 2014 to early April 2015 (http://www.
4 | DISCUSSION                                                                  chp.gov.hk/en/sas6/101/110/106.html). Over 95% of A/H3N2 in
                                                                                2014/15 season was A/Switzerland/9715293/2013-­like, which was
Mild laboratory-­confirmed influenza in children was common during              mismatched from A/Texas/50/2012 (H3N2)-­like virus being included
influenza seasons in 2014 and 2015. Influenza vaccine uptake was                in the recommended seasonal vaccine. Our molecular typing assay
       |




                                                                                                                                                           17502659, 2017, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/irv.12455, Wiley Online Library on [17/11/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
324                                                                                                                                        LEUNG et al.


                                                                                                        T A B L E 3 Influenza vaccine
                               Timing of                       Not
                                                                                                        effectiveness (VE) for mild laboratory-­
 Outcome                       Vaccination     Vaccinated      vaccinated    VE (%)
                                                                                                        confirmed influenza and influenza-­like
 Mild laboratory-­             Within 3 y      n=333           n=290          17.5 (−39.0-­51.3)        illness among all 623 preschool and
  confirmed influenza by         Positive       26 (7.8)        27 (9.3)                                school-­age children
  surveillance
                                 Negative      307 (92.2)      263 (90.7)
                               Within 12 mo    n=266           n=357          33.2 (−16.9-­62.2)
                                 Positive       18 (6.8)        35 (9.8)
                                 Negative      248 (93.2)      322 (90.2)
                               13-­24 mo ago   n=256           n=367           6.4 (−58.8-­44.9)
                                 Positive       21 (8.2)        32 (8.7)
                                 Negative      235 (91.8)      335 (91.3)
                               25-­36 mo ago   n=240           n=383         −14.6 (−92.2-­31.5)
                                 Positive       22 (9.2)        31 (8.1)
                                 Negative      218 (90.8)      352 (91.9)
 Influenza-­like illness       Within 3 y      n=333           n=290          49.4 (24.0-­66.9)
                                 With ILI       39 (11.7)       60 (20.8)
                                 No ILI        294 (88.3)      229 (79.2)
                               Within 12 mo    n=266           n=357          50.0 (22.4-­68.4)
                                 With ILI       29 (10.9)       70 (19.6)
                                 No ILI        237 (89.1)      287 (80.4)
                               13-­24 mo ago   n=256           n=367          51.9 (24.5-­70.1)
                                 With ILI       27 (10.5)       72 (19.6)
                                 No ILI        229 (89.5)      295 (80.4)
                               25-­36 mo ago   n=240           n=383          42.1 (10.5-­63.1)
                                 With ILI       28 (11.7)       71 (18.5)
                                 No ILI        212 (88.3)      312 (81.5)

Results expressed in number (percentage) for influenza outcomes and mean (95% confidence interval)
for VE.



was designed to detect both of these A/H3N2 strains. All influenza              We found that influenza vaccination was effective against ILI but
B viruses by our surveillance were detected in 2014, with nine being        not mild infection identified by 2-­weekly surveillance during influenza
in B/Yamagata-­lineage and 10 being in B/Victoria-­lineage. Whereas         seasons, which was surprising given that all the non-­influenza causes
the unpredictability of circulating influenza B was known28, our typing     of ILI would reduce the observed strength of influenza VE toward the
results were concordant with local CHP data for B/Yamagata-­lineage         null. One possible explanation relates to study power that we detected
dominance in early 2014 and low activity (8.4% of isolates) of influ-       many more patients of ILI (n=99) than mild influenza infection (n=57).
enza B in 2014/2015 winter season.                                          On the other hand, influenza-­infected children were reported to have
      Our government has included children aged 6 months to                 increased susceptibility to co-­infection by other respiratory patho-
5 years as a priority group in the influenza vaccination subsidy            gens, notably pneumococcus and staphylococcus, which increased the
scheme. Nonetheless, a small local study found <20% uptake rate             severity of their RTIs.30-32 Thus, it is also possible that influenza vacci-
                           7
in preschool children. In this study, 36%-­44% of children received         nation prevented ILI by reducing the children with such co-­infections.
influenza vaccination annually (Table 1). Uptake of influenza vacci-        Vaccinated and unvaccinated patients with influenza infections may
nation was also low among local healthcare workers in the post-­            exhibit different health care-­seeking behavior. This study adopted the
pandemic era.29 Breaking barriers to accept influenza vaccination           test-­negative design to define influenza VE as it is less susceptible to
should be a public health priority in fighting against influenza out-       bias due to misclassification of infection and to confounding by health
breaks. Our findings of moderate overall influenza VE for ILI in            care-­seeking behavior relative to traditional case-­control or cohort
children aged 2-­12 years together with higher VE against both ILI          studies.14,33
and mild laboratory-­confirmed influenza among the subgroup of                  Different studies reported that influenza vaccination lowered sub-
school-­age children may represent an additional strategy where the         ject hospitalization rate by 50%-­66%.5,19,20 In our research proposal, we
Government Vaccination Program can be expanded to cover chil-               targeted to recruit 560 children with evaluable study outcomes which
dren up to 12 years old.                                                    was based on the assumptions of 40% influenza vaccination coverage,
                                                                                                                                                                                                                                                                                                                          LEUNG et al.




               TABLE 4            Influenza vaccine effectiveness (VE) in the subgroups of 387 school-­age and 236 preschool children

                                                                                                       School-­age children                                                                                      Preschool children
                                                                    Timing of
                 Outcome                                            vaccination                        Vaccinated                    Not vaccinated                       VE (%)                                 Vaccinated                    Not vaccinated                      VE (%)

                 Mild laboratory-­confirmed                         Within 3 y                         n=210                         n=177                                30.4 (−28.6-­62.8)                     n=123                         n=113                               −19.5 (−208.1-­53.1)
                  influenza by surveillance                             Positive                         18 (8.6)                      21 (11.9)                                                                    9 (7.3)                        7 (6.2)
                                                                        Negative                       192 (91.4)                    156 (88.1)                                                                  114 (92.7)                    106 (93.8)
                                                                    Within 12 mo                       n=166                         n=221                                44.0 (−10.1-­72.3)                     n=100                         n=136                                 −6.2 (−174.8-­58.8)
                                                                        Positive                         12 (7.2)                      27 (12.2)                                                                    7 (7.0)                        9 (6.6)
                                                                        Negative                       154 (92.8)                    194 (87.8)                                                                    93 (93.0)                   127 (93.4)
                                                                    13-­24 mo ago                      n=166                         n=221                                18.5 (−51.9-­56.6)                     n=90                          n=146                               −28.4 (−229.2-­49.1)
                                                                        Positive                         15 (9.0)                      24 (10.9)                                                                    7 (7.8)                        9 (6.2)
                                                                        Negative                       151 (91.0)                    197 (89.1)                                                                    83 (92.2)                   137 (93.8)
                                                                    25-­36 mo ago                      n=165                         n=222                                 7.1 (−70.8-­49.6)                     n=75                          n=161                               −73.9(−338.2-­28.5)
                                                                        Positive                         16 (9.7)                      23 (10.4)                                                                    7 (9.3)                        9 (5.6)
                                                                        Negative                       149 (90.3)                    199 (89.6)                                                                    68 (90.7)                   152 (94.4)
                 Influenza-­like illness                            Within 3 y                         n=210                         n=177                                66.4 (30.3-­84.7)                      n=123                         n=113                                 34.3 (−4.8-­59.8)
                                                                        With ILI                         11 (5.2)                      25 (14.1)                                                                   28 (22.8)                     35 (31.0)
                                                                        No ILI                         199 (94.8)                    152 (85.9)                                                                    95 (77.2)                     78 (69.0)
                                                                    Within 12 mo                       n=166                         n=221                                70.9 (31.4-­88.6)                      n=100                         n=136                                 34.6 (−6.7-­61.0)
                                                                        With ILI                           7 (4.2)                     29 (13.1)                                                                   22 (22.0)                     41 (30.1)
                                                                        No ILI                         159 (95.8)                    192 (86.9)                                                                    78 (78.0)                     95 (69.9)
                                                                    13-­24 mo ago                      n=166                         n=221                                58.8 (11.4-­81.8)                      n=90                          n=146                                 43.9 (4.0-­68.6)
                                                                        With ILI                           9 (5.4)                     27 (12.2)                                                                   18 (20.0)                     45 (30.8)
                                                                        No ILI                         157 (94.6)                    194 (87.8)                                                                    72 (80.0)                   101 (69.2)
                                                                    25-­36 mo ago                      n=165                         n=222                                43.7 (−13.9-­72.9)                     n=75                          n=161                                 26.7 (−22.7-­57.1)
                                                                        With ILI                         11 (6.7)                      25 (11.3)                                                                   17 (22.7)                     46 (28.6)
                                                                        No ILI                         154 (93.3)                    197 (88.7)                                                                    58 (77.3)                   115 (71.4)

               Results expressed in number (percentage) for influenza outcomes and mean (95% confidence interval) for VE.
                                                                                                                                                                                                                                                                                                                         | 325




17502659, 2017, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/irv.12455, Wiley Online Library on [17/11/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
       |




                                                                                                                                                         17502659, 2017, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/irv.12455, Wiley Online Library on [17/11/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
326                                                                                                                                      LEUNG et al.


respective influenza attack rates of 13% and 25% among vaccinees           REFERENCES
and non-­vaccinees, and 30% dropout during the surveillance period.         1. Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS. Influenza-­related
Whereas our cohort of 623 subjects should be sufficient to detect the          hospitalizations among children in Hong Kong. N Engl J Med.
difference in ILI between vaccinated and non-­vaccinated children, this        2002;347:2097‐2103.
study might not be sufficiently powered to detect the observed differ-      2. Chiu SS, Chan KH, Chen H, et al. Virologically confirmed population-­
                                                                               based burden of hospitalization caused by influenza A and B among
ence in laboratory-­confirmed influenza among our subjects. Another
                                                                               children in Hong Kong. Clin Infect Dis. 2009;49:1016‐1021.
limitation relates to our inability to detect symptomatic moderate-­to-­    3. Scientific Committee on Vaccine Preventable Diseases, Centre
severe laboratory-­confirmed influenza. Students absent on the days            for Health Protection. Recommendations on Seasonal Influenza
of school visits were not sampled. Because of frequent school visits,          Vaccination for the 2012/13 Season. http://www.chp.gov.hk/files/
                                                                               pdf/recommendations_on_seasonal_influenza_vaccination_for_
our nurses could not arrange home visits for collecting FNPS from
                                                                               the_201213_season.pdf; 2012. Accessed October 11, 2012.
children with ILI for influenza testing. For influenza A(H1N1)pdm09         4. Kissling E, Valenciano M, I-MOVE case-control studies team. Early
infection, the revised WHO ILI case definition with fever and cough            estimates of seasonal influenza vaccine effectiveness in Europe
had low sensitivity (36%) but higher positive predictive value (42%)           among target groups for vaccination: results from the I-­        MOVE
                                                                               multicentre case-­  control study, 2011/12. Euro Surveill. 2012;17:
and positive likelihood ratio (13.3) than the other case definitions.34
                                                                               pii=20146.
In a Taiwanese study, the presence of fever, cough and sneezing             5. Yang Z, Dong Z, Fu C. Seasonal influenza vaccine effectiveness
had the best specificity (77%) for laboratory-­confirmed influenza.35          among children aged 6 to 59 months in southern China. PLoS ONE.
Different ILI case definitions adopted in Europe, USA, and Taiwan              2012;7:e30424.
                                                                            6. Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemiology of
had comparable accuracy in sensitivity and specificity, and clinical
                                                                               pandemic and seasonal influenza A in households. N Engl J Med.
diagnosis of ILI was useful for providing valuable information for sur-        2010;362:2175‐2184.
veillance purpose. This study defined ILI by revised criteria that in-      7. Leung TF, Tse LY, Ngai KL, et al. Surveillance for Influenza and
cluded other respiratory and constitutional symptoms. It is likely that        Rhinovirus Infections in Hong Kong Preschool Children, abstr 927.
                                                                               Abstr 32nd Annual Meeting of European Society of Pediatric Infectious
our patients with ILI had influenza during influenza seasons. Another
                                                                               Diseases. European Society of Pediatric Infectious Diseases, Geneva,
limitation relates to low participation rates of kindergartens (10/238)        Switzerland, 2014.05.06.
and primary schools (5/97), which raised concern if our subjects were       8. Centers for Disease Control and Prevention. Interim within-­season
recruited by convenience sampling. Nonetheless, we believe our sur-            estimate of the effectiveness of trivalent inactivated influenza vac-
veillance data were generalizable because these kindergartens and              cine -­Marshfield, Wisconsin, 2007-­08 influenza season. Morb Mortal
                                                                               Wkly Rep. 2008;57:393‐398.
primary schools were identified in sequential random batches from
                                                                            9. Hua S, Li X, Liu M, et al. Antigenic variation of the human influenza A
all in our target geographic regions that were registered under the            (H3N2) virus during the 2014-­2015 winter season. Sci China Life Sci.
Education Bureau. This study was also limited by the lack of surveil-          2015;58:882‐888.
lance data for subjects’ household and class contacts. Most secondary      10. World Health Organization. Global Epidemiological Surveillance
                                                                               Standards for Influenza. Geneva; 201314.
cases in this surveillance were expected to have minimal influenza
                                                                           11. Sung RY, Chan PK, Choi KC, et al. Comparative study of nasopharyn-
symptoms due to low viral load. Unless we collect surveillance sam-            geal aspirate and nasal swab specimens for diagnosis of acute viral
ples from subjects’ close contacts, we shall miss these secondary              respiratory. J Clin Microbiol. 2008;46:3073‐3076.
cases by only calling them for any ILI symptom.                            12. Heikkinen T, Salmi AS, Ruuskanen O. Comparative study of nasopha-
                                                                               ryngeal aspirate and nasal swab specimens for detection of influenza.
      In conclusion, mild laboratory-­confirmed influenza was common
                                                                               BMJ. 2001;322:138.
among children during influenza seasons in 2014-­2015. Moderate            13. Chan MC, Chan RW, Yu WC, et al. Tropism and innate host responses
overall influenza VE was found for ILI, and subgroup analyses sug-             of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro
gested higher VE for both ILI and mild laboratory-­confirmed influ-            cultures of human conjunctiva and respiratory tract. Am J Pathol.
                                                                               2010;176:1828‐1840.
enza in school-­age children. Whether vaccination prevented influenza
                                                                           14. Jackson ML, Nelson JC. The test-­negative design for estimating influ-
transmission within families or classes remained unanswered due to             enza vaccine effectiveness. Vaccine. 2013;31:2165‐2168.
lack of reported secondary cases.                                          15. Olivier CW. Influenza vaccination coverage rate in children. rea-
                                                                               sons for a failure and how to go forward. Hum Vaccin Immunother.
                                                                               2012;8:107‐118.
CO NFLI CT OF I NTERE S T                                                  16. Chor JS, Ngai KL, Goggins WB, et al. Willingness of Hong Kong health-
                                                                               care workers to accept pre-­pandemic influenza vaccination at differ-
All authors declared no conflict of interest.
                                                                               ent WHO alert levels: two questionnaire surveys. BMJ. 2009;339:
                                                                               b3391.
                                                                           17. Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H. Seasonal in-
ACKNOWLE DGE ME N T
                                                                               fluenza vaccination coverage in France during two influenza seasons
We thank principals and responsible teachers of participating kin-             (2007 and 2008) and during a context of pandemic influenza A(H1N1)
                                                                               in 2009. Vaccine. 2011;29:4632‐4637.
dergartens and primary schools for supporting school visits. We also
                                                                           18. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M.
thank Clara Yu, Yuen M. Chan, Nancy Cheng, Wanny Leung, Elsa                   Immune response after a single vaccination against 2009 influenza
Chan, Elaine Wong, Karene Chan, and Apple Yeung for helping with               A H1N1 in USA: a preliminary report of two randomised controlled
field works and FNPS processing.                                               phase 2 trials. Lancet. 2010;375:41‐48.
                                                                                                                                                     | 327




                                                                                                                                                               17502659, 2017, 4, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/irv.12455, Wiley Online Library on [17/11/2025]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
LEUNG et al.


19. Orellano PW, Reynoso JI, Carlino O, Uez O. Protection of trivalent in-      28. Chan PK, Chan MC, Cheung JL, et al. Influenza B lineage circulation
    activated influenza vaccine against hospitalizations among pandemic             and hospitalization rates in a subtropical city, Hong Kong, 2000-­2010.
    influenza A (H1N1) cases in Argentina. Vaccine. 2010;28:5288‐5291.              Clin Infect Dis. 2013;56:677‐684.
20. Skowronski DM, Woolcott JC, Tweed SA, Brunham RC, Marra                     29. Chor JS, Pada SK, Stephenson I, et al. Seasonal influenza vaccination
    F. Potential cost-­  effectiveness of annual influenza immuniza-                predicts pandemic H1N1 vaccination uptake among healthcare work-
    tion for infants and toddlers: experience from Canada. Vaccine.                 ers in three countries. Vaccine. 2011;29:7364‐7369.
    2006;24:4222‐4232.                                                          30. Blyth CC, Webb SA, Kok J, et al. The impact of bacterial and viral
21. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effec-             co-­infection in severe influenza. Influenza Other Respir Viruses.
    tiveness of influenza vaccines: a systematic review and meta-­analysis.         2013;7:168‐176.
    Lancet Infect Dis. 2012;12:36‐44.                                           31. Wolter N, Tempia S, Cohen C, et al. High nasopharyngeal pneumococ-
22. Word Health Organization. Recommended Composition of Influenza                  cal density, increased by viral coinfection, is associated with invasive
    Virus Vaccines for use in the 2012-2013 Northern Hemisphere Influenza           pneumococcal pneumonia. J Infect Dis. 2014;210:1649‐1657.
    Season.     http://www.who.int/influenza/vaccines/virus/recommenda-         32. Wei L, Liu W, Zhang XA, et al. Detection of viral and bacterial
    tions/201202_recommendation.pdf; 2012. Accessed January 24, 2013.               pathogens in hospitalized children with acute respiratory illnesses,
23. Cowling BJ, Kwan MY, Wong JS, et al. Interim estimates of the effec-            Chongqing, 2009-­2013. Medicine (Baltimore). 2015;94:e742.
    tiveness of influenza vaccination against influenza-­associated hospi-      33. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-­negative
    talization in children in Hong Kong, 2015-­16. Influenza Other Respir           design for studies of the effectiveness of influenza vaccine. Vaccine.
    Viruses. 2017;11:61‐65.                                                         2013;31:3104‐3109.
24. Qin Y, Zhang Y, Wu P, et al. Influenza vaccine effectiveness in pre-        34. Jiang L, Lee VJ, Lim WY, et al. Performance of case definitions for in-
    venting hospitalization among Beijing residents in China, 2013-­15.             fluenza surveillance. Euro Surveill. 2015;20:21145.
    Vaccine. 2016;34:2329‐2333.                                                 35. Yang JH, Huang PY, Shie SS, et al. Predictive symptoms and
25. Sugaya N, Shinjoh M, Kawakami C, et al. Trivalent inactivated influ-            signs of laboratory-­  confirmed influenza: a prospective surveil-
    enza vaccine effective against influenza A(H3N2) variant viruses in             lance study of two metropolitan areas in Taiwan. Medicine (Baltimore).
    children during the 2014/15 season, Japan. Euro Surveill 2016;21:               2015;94:e1952.
    pii=30377.
26. Caspard H, Gaglani M, Clipper L, et al. Effectiveness of live atten-
    uated influenza vaccine and inactivated influenza vaccine in chil-
                                                                                   How to cite this article: Leung TF, Chan RWY, Kwok A, et al.
    dren 2-­17 years of age in 2013-­2014 in the United States. Vaccine.
                                                                                   School-­based surveillance for influenza vaccine effectiveness
    2016;34:77‐82.
27. Zimmerman RK, Nowalk MP, Chung J, et al. 2014-­2015 influenza vac-             during 2014-­2015 seasons in Hong Kong. Influenza Other Respi
    cine effectiveness in the United States by vaccine type. Clin Infect Dis.      Viruses. 2017;11:319‐327. https://doi.org/10.1111/irv.12455
    2016;63:1564‐1573.
